Navigation Links
Eloxatin in Medical News

Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

...eria . No patient in any dose group exhibited any signs of acute neurotoxicity, which is a major adverse side-effect of the approved DACH platinum, eloxatin , and ProLindac was well tolerated overall. The Company has scaled up manufacturing in order to begin the next phase of clinical development. Access ...

Sanofi-aventis Announces Good First-quarter 2009 Performance

...cation approved in the second half of 2008. In the United States, the product posted 2.9% growth in net sales to euro 197 million. Net sales of eloxatin (R) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and as first line treatment in the metastatic phase, were up 3.0% at...

Sanofi-aventis Delivers 2008 Results Above Guidance

...sed by 17.8% (to EUR 49 million) in the fourth quarter and by 14.9% (to EUR 142 million) over the full year. In the United States, net sales of eloxatin (R) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and in the metastatic phase, rose by 6.9% to EUR 265 million in the ...

Eloxatin combination reduces bowel cancer recurrences

...study involving patients taking supplementation of eloxatin drug with other chemotherapeutic cancer drug for t...s called as NICE study has proved a combination of eloxatin with chemotherapeutic drugs more effective than co...nic acid. The study has found combination of eloxatin with 5-Fluorouracil and Folinic acid more effectiv...
Eloxatin in Medical Technology

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

... noted Dr. de Gramont. "Inclusion of these survival results in the new U.S. eloxatin PI marks an important milestone in the treatment of colon cancer." About ...two weeks for 12 cycles. The primary endpoint evaluated how the addition of eloxatin affected disease-free survival at three years. Secondary endpoints included...

Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review

...r Stage III colon cancer patients." In the MOSAIC trial, Stage III colon cancer patients treated after complete surgical resection of the tumor with eloxatin in combination with infusional 5-FU/LV had a significant reduction (20%) in the risk of dying after a median of six years compared to standard 5FU/LV-...

Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research

...atment of patients with advanced carcinoma of the colon or rectum. In 2004, eloxatin received additional approval for the first-line treatment of these patients. Based on data showing improvement in disease-free survival, eloxatin was also approved in 2004 for use in combination with infusional 5-FU/LV in...

The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer

...s were resected; of these, 115 patients (63%) received post-operative chemotherapy. In the standard arm, 152 patients' liver metastases were resected. eloxatin is not approved for peri-operative use in the United States. About Colorectal Cancer Colorectal cancer is a leading cause of death. Every year, ab...
Eloxatin in Medical Dictionary

Injection

...se. Read more about the prescription drug OXALIPLATIN - INJECTION . ... home > oxaliplatin- injection index > oxaliplatin- injection , eloxatin drug monograph ... Consumer information about the medication FOLIC ACID - INJECTION (Folvite), includes side effects, drug interactions, rec...
Eloxatin in Biological Technology

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...in New York (NYSE: SNY ). For more information, visit: www.sanofi-aventis.us or www.sanofi-aventis.com . Please see the accompanying eloxatin (oxaliplatin injection), Lovenox (enoxaparin sodium injection), and Taxotere (docetaxel) Injection Concentrate full prescribing information, including...

Sanofi-aventis Announces Second Quarter 2009 Results

...h metastatic breast cancer, based on the results of the AVADO study. First-half net sales of Taxotere((R)) were up 9.5% at euro 1,118 million. eloxatin ((R)) , the leading cytotoxic agent in the colorectal cancer market as an adjuvant and as a first-line treatment in the metastatic phase, achieved se...

Hospira Receives Favorable Court Decision on Eloxatin(R)

...e generic name oxaliplatin injection, will be one of the first generic versions available in the United States to come in solution form. U.S. sales of eloxatin last year were approximately $1.4 billion. "We are extremely pleased with the court's ruling," said Joshua Gordon, vice president, Specialty Phar...

Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

...). Results also continue to indicate that both regimens have similar anti-tumor activity in first-line metastatic CRC. Net sales in 2007 in the US for eloxatin (oxaliplatin) were approximately $1.3 billion. "These new data continue to suggest that picoplatin is an active platinum agent in colorectal canc...

Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL

...ug Application (ANDA) containing a paragraph IV certification for a generic eloxatin product with the U.S. Food & Drug Administration (FDA), and following FDA n...rmally initiates the patent challenge process under the Hatch-Waxman Act. eloxatin (Oxaliplatin Aqueous Solution), 5mg/mL Injectable, used in combination with...

Access Highlighted in Recent BusinessWeek Article

...rcial also noted that Dr. Esteban Cvitkovic, Access' Vice-Chairman (Europe) and Senior Director, Oncology Clinical R&D, was responsible for developing eloxatin during his tenure at Sanofi-Aventis. The article references certain products of Somanta Pharmaceuticals in the cancer area. While Access has executed ...
Other Tags
(Date:5/28/2015)... (PRWEB) May 28, 2015 The MIT ... case study featuring Healthcare IQ. Members of the MIT ... senior management team to develop the case study about ... healthcare analytics. , The case study, ‘Healthcare IQ: Competing ... IQ from its beginning as a hospital financial software ...
(Date:5/28/2015)... First Choice Emergency Room , the ... United States, announced that it is expanding in the ... Ranch facility. , “I am pleased to announce ... quality emergency medical care to Denver residents with our ... James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Orem, UT—Dymicron, ... in-human surgeries using their unique Triadyme-C cervical total disc ... surgeon Dr. William D. Smith at the American Institute ... “The patients are responding well to the implantation of ... of AIMIS Spine Center and Chief of Neurosurgery for ...
(Date:5/28/2015)... Career Step, an online provider of career-focused education ... Step Executive Vice President Mike Hodgson will be a ... ICD10monitor in conjunction with Kimberly J. Carr the Director ... Carr will be discussing the importance of auditing and ... have worked closely with HRS on a number of ...
(Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... announced that it will participate as an exhibitor at ... to be held June 9-14, 2015 in New Orleans, ... opportunities, and exhibits with products and services. , ... will be available to speak with attendees about its ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 3Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
Other Contents